soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine 🧿 Oral semaglutide is the

Strategies for managing this period include meal prepping in advance so healthy options are immediately available, maintaining the eating patterns you developed on tirzepatide, adding protein to every meal and snack for sustained satiety, and staying busy during traditionally difficult times (evenings and weekends)

The placebo group lost 3.1%

See What Our Patients Have to Say About STL Weight Loss Injections A before and after of a patient within four months

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

With semaglutide GLP-1, the first hormone-based weight loss medication of its kind, a new generation of safe, effective weight loss medications is now available